Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
FPA Supports HB 547/SB692: Access to Pharmacists Services Act SUMMARY: Revise the definition of “practice of the profession of pharmacy.” This bill revises the definition of the practice of the profession of pharmacy to allow a pharmacist to: Consult on the therapeutic values and interactions of patent or proprietary products and health and wellness assessments and patient care relating to medication therapy management; Manage, in addition to monitor and review, a patient’s drug therapy; Collaborate with a patient’s health care provider, the provider’s authorized agent, or other persons specifically authorized by the patient regarding the patient’s health care status, in addition to the patient’s drug therapy; and Dispense medications, including vaccines, in addition to the administration of such medications. This bill will expand the abilities that consultant pharmacists and doctors of pharmacy have by allowing them to perform medication management, patient health and wellness assessments, counseling and referrals relating to medications and health care services in accordance with the current laws and standards. Under this bill consultant pharmacists and doctors of pharmacy will: ● Have the ability to order and evaluate diagnostic, laboratory, or clinical testing without authorization by a physician. ● Initiate, modify, discontinue, and administer drugs within the context of a drug therapy management protocol or order in collaboration with one or more health care providers. The bill also allows for the reimbursement for patient care services apart from medication prescriptions by health benefit plans or insurers. Currently Postponed in the House and Withdrawn in the Senate